Expression of TSLC1 in patients with HAM/TSP

Area of Science:

• Neuroimmunology
• Virology
• Immunology

Background:

• Human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a chronic neurological disorder.
• Current biomarkers for HAM/TSP disease activity are limited to cerebrospinal fluid.
• Peripheral blood biomarkers for HAM/TSP activity are needed.

Purpose of the Study:

• To investigate the expression levels of adhesion molecules in peripheral blood T cells in relation to HAM/TSP disease activity.
• To identify potential peripheral blood biomarkers for monitoring HAM/TSP progression.

Main Methods:

• Flow cytometry was used to analyze the expression of adhesion molecules, including TSLC1, LFA-1, and DnM-1, on CD4+ and CD8+ T cells.
• Expression levels were compared between HAM/TSP patients, asymptomatic HTLV-1 carriers, and healthy controls.
• Correlation with disease severity and viral transcription factors (Tax, HBZ) was assessed.

Main Results:

• TSLC1 expression was significantly higher in CD4+ T cells of HAM/TSP patients compared to controls and carriers.
• Increased TSLC1 expression in CD4+ T cells correlated with worsening HAM/TSP symptoms.
• Conversely, TSLC1 expression was lower in CD8+ T cells of HAM/TSP patients, with a stronger decrease in those with advanced symptoms.
• No correlation was found between TSLC1 expression and Tax or HBZ transcription factors.

Conclusions:

• TSLC1 expression in CD4+ T cells shows potential as a peripheral blood biomarker for HAM/TSP disease activity.
• This finding could aid in non-invasive monitoring and management of HAM/TSP.
• Further research is warranted to validate TSLC1 as a reliable biomarker.